BioSpace News Archive

Pharm Country

Intact Vascular to Sponsor Post-Angioplasty Dissection Symposium at 2019 New Cardiovascular Horizons Conference

Presentations Highlight the Tack Endovascular System® for Focal Dissection Repair Device Following Balloon Angioplasty

May 20, 2019
·
4 min read
Business

Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension

Owlstone Medical announces a strategic collaboration with Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson and a global leader in pulmonary arterial hypertension, to discover and validate a breath-based test to help facilitate the early diagnosis of pulmonary hypertension and its subtypes.

May 20, 2019
·
2 min read
Business

TTP plc Collaborates with Quotient Ltd to Transform Transfusion Diagnostics and Beyond

TTP enables development of MosaiQ™ diagnostic platform for transfusion typing and disease screening

May 20, 2019
·
3 min read
Business

Magellan Rx Management’s Second Annual Employer Market Insights Report Highlights Market Dynamics and Opportunities for Traditional and Specialty Drugs

Unique report provides current and forward-looking pharmacy trends and cost management strategies for 2020 and beyond

May 20, 2019
·
3 min read
Pharm Country

Young People Disproportionately Represented in Increased Private Insurance Claims for Mental Health Diagnoses, 10-Year Study Finds

FAIR Health Study Reveals Pediatric Share of Major Depressive Disorder Claim Lines Grew from 15 Percent in 2007 to 23 Percent in 2017

May 20, 2019
·
5 min read
Drug Development

SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors

SpringWorks Therapeutics announced that the first patient has been dosed in the Phase 3 “DeFi” trial evaluating nirogacestat, an oral, selective, small molecule gamma-secretase inhibitor, in adult patients with progressing desmoid tumors.

May 20, 2019
·
6 min read
Gelymar Doubles its Production Capacity

Sustainable strategy drive demand and expansion for renewable carrageenan

May 20, 2019
·
3 min read
Deals

NanoViricides Files Quarterly Report for Period Ending March 31, 2019 - HerpeCide™ Drug Candidate Pre-IND Application Submitted, Progressing Towards Clinical Trials

NanoViricides, Inc. a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, has filed its quarterly report for its third quarter of financial year 2019 in a timely manner with the Securities and Exchange Commission.

May 20, 2019
·
10 min read
Drug Development

Can-Fite’s Phase II Liver Cancer Data Selected for Presentation at a Leading Liver Cancer Scientific Forum (ILCA)

Can-Fite BioPharma Ltd. announced that the International Liver Cancer Association has accepted Can-Fite’s abstract describing the latest data from the Company’s Phase II Liver Cancer study of Namodenoson for an oral presentation at its annual conference.

May 20, 2019
·
6 min read
Genetown

KalVista Pharmaceuticals to Present Data at Upcoming Scientific Conferences

Phase 1 Data on Oral Plasma Kallikrein Inhibitor KVD900 for Potential On-Demand Treatment of HAE Attacks to be Presented

May 20, 2019
·
3 min read